First look: Princeton researchers peek into deepest recesses of human brain

A team of scientists from Princeton University has devised a new experimental technique that produces some of the best functional images ever taken of the human brainstem, the most primitive area of the brain.

The scientists believe they may be opening the door to inquiries into a region that acts as the staging area for the brain chemicals whose overabundance or absence in other parts of the brain are at the root of many neuropsychiatric disorders, like addiction, schizophrenia and Parkinson's disease.

Reporting in the Feb. 28 edition of Science, the scientists describe using functional magnetic resonance imaging to study brainstem activity in dehydrated humans. The scanning technique allows researchers to watch the brain in action.

The subjects were participating in classical conditioning experiments in which they were presented with a visual clue, then, at varying intervals, given a drink. The researchers were able to track changes in blood flow in areas of the brainstem associated with enhanced activity of the brain chemical dopamine -- as the person experienced either pleasure or disappointment at receiving or not receiving the reward.

"For a long time, scientists have tried looking at this area of the brain and have been unsuccessful -- it's just too small," said Kimberlee D'Ardenne, the lead author on the paper. Until now, scientists wanting to use brain scans to study brain chemicals like dopamine were relegated to watching its effects in other more accessible parts of the brain, like the prefrontal cortex and ventral striatum. However, this was downstream of its source, and therefore possibly much less accurate, D'Ardenne said.

"We wanted to try because the brainstem is so important to activities in the rest of the brain," said D'Ardenne, a postdoctoral student in the Department of Chemistry. "We believe it could be a key to understanding all kinds of important behavior."

For the research, D'Ardenne collaborated with Jonathan Cohen, co-director of the Princeton Neuroscience Institute, and Samuel McClure and Leigh Nystrom, other institute scientists. They conducted the studies on the University's own brain scanner located on campus in Green Hall.

Cohen noted that these findings provide a critical link between studies in non-human animals that have looked directly at the activity of dopamine cells in the brainstem and studies in humans of behaviors thought to be related to dopamine. "It could also open up entirely new avenues of study," he said.

The team was able to develop high-resolution images that tracked the activity of tiny clusters of dopamine neurons. They weeded out distortions caused by many pulsing blood vessels in the brainstem. They also employed computerized rules of thumb known as algorithms and imaging techniques to reduce the effects of head movement and combine images from different subjects.

The MRI device produces three-dimensional images that show what portions of the brain engage during actions and thought processes. This allows the investigators to correlate physical processes with mental activities with unprecedented precision.

The brain stem, a tiny, root-shaped structure, is the lower part of the brain and sits atop the spinal cord. The area controls brain functions necessary for survival, such as breathing, digestion, heart rate, blood pressure and arousal. The brain structure also serves as the home base for the brain chemicals, also known as neuromodulators, such as dopamine, serotonin and norepinephrine. The chemicals spring forth into other brain regions from there, zipping along routes called axons.

The team's experiments confirmed results already seen in animal studies. Blood flow increased in dopamine centers of the brainstem when test subjects were happily surprised with a reward. However, there was no activity when participants received less than what they expected, a finding that is different from the results of previous studies looking farther downstream.

"We are just at the beginning of understanding these crucial pathways," D'Ardenne said. "But it gives us a hint about what is possible to know."

The tiny clumps of cells containing neuromodulator chemicals in the brainstem, called nuclei, have long been known to play a critical role in the regulation of brain function, and disturbances of these systems have been implicated in most psychiatric disorders, from addiction to schizophrenia, D'Ardenne said.

The Princeton group wants to understand how the brain's physical structures give rise to the functions of the mind, a field known as cognitive neuroscience.

For years, neuroscientists focused on the brain while psychologists dealt with the mind. The new field combines both and is being powered by scientific advances in brain imaging and gene manipulation that allows researchers to record and measure the activity of brain cells as humans or animals perform mental tasks.

Source: Princeton University

Related stories:

Deafness and seizures result when mysterious protein deleted in mice
Scientists have discovered that mice genetically engineered to lack a particular protein in the brain have profound deafness and seizures. The finding suggests a pathway, they say, for exploring the hereditary causes of deafness and epilepsy in humans.
Surgical technique halts cell loss, Parkinson's researchers find
Deep brain stimulation, a surgical technique often viewed as a last resort for people with Parkinson's disease, halts the progression of dopamine-cell loss in animal models, according to preliminary research by scientists at the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital.
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. At the same time an Austrian scientist, Dr. Hans Asperger, described a milder form of the disorder that became known as Asperger Syndrome, characterised by higher cognitive abilities and more normal language function. Today, both disorders are classified in the continuum of 'Pervasive Developmental Disorders' (PDD), more often referred to as Autism Spectrum Disorders (ASD).
UC team studies link between Parkinson's disease and depression
A patient who receives a diagnosis of Parkinson's disease might become depressed, and understandably so. But does the depression then exacerbate the progression of Parkinson's?
Treadmill exercise retrains brain and body of stroke victims
People who walk on a treadmill even years after stroke damage can significantly improve their health and mobility, changes that reflect actual "rewiring" of their brains, according to research spearheaded at Johns Hopkins.
Cocaine: How addiction develops
Permanent drug seeking and relapse after renewed drug administration are typical behavioral patterns of addiction. Molecular changes at the connection points in the brain's reward center are directly responsible for this. This finding was published by a research team from the Institute of Mental Health (ZI) in Mannheim, the German Cancer Research Center (DKFZ) in Heidelberg and the University of Geneva, Switzerland, in the latest issue of Neuron. The results provide researchers with new approaches in the medical treatment of drug addiction.
1 sleepless night increases dopamine in the human brain
Just one night without sleep can increase the amount of the chemical dopamine in the human brain, according to new imaging research in the August 20 issue of The Journal of Neuroscience. Because drugs that increase dopamine, like amphetamines, promote wakefulness, the findings offer a potential mechanism explaining how the brain helps people stay awake despite the urge to sleep. However, the study also shows that the increase in dopamine cannot compensate for the cognitive deficits caused by sleep deprivation.
Study finds way to prevent protein clumping characteristic of Parkinson's disease
Researchers at the University of Pennsylvania School of Medicine have identified a protein from a most unlikely source -- baker's yeast -- that might protect against Parkinson's disease. More than a million Americans suffer from Parkinson's disease, and no treatments are available that fundamentally alter the course of the condition. By introducing the yeast protein Hsp104 into animal models of Parkinson's disease, researchers prevented protein clumping that leads to nerve cell death characteristic of the disorder.

News discussion:

Medicine & Health news